Xtant Medical Holdings, Inc.
XTNT- Exchange
- NYSE
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001453593
No open-market purchases or sales by Xtant Medical Holdings, Inc. insiders were filed in the last 90 days; 33 institutions reported holding it in 13F filings for Q2 2026, worth $33.8M in total; no superinvestor holds it.
Key figures
- Market capClose on Nov 13, 2026
- $38.1M
- Insider buysOpen market, last 90 days
- 0
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ2 2026, −1 vs. previous quarter
- 33
- 13F valueReported value at the end of Q2 2026
- $33.8M
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Financials
See financial statementsFrom SEC filings, in USD.
- Revenue, FY2025
- $133.9M
- +14.2% year over year
- Net income, FY2025
- $4.97M
- No comparable prior period
- Free cash flow, FY2025
- $10.2M
- No comparable prior period
- Revenue, Q2 FY2026
- $23.0M
- −35.0% year over year
Revenue flow, FY2025
Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue.
Short interest
See short dataFrom FINRA, settlement date Oct 30, 2026.
- Short interest
- 375.3K
- Shares sold short
- Change
- +74.8K
- +24.9% vs. previous
- Days to cover
- 3.86
- At average daily volume
Superinvestors holding XTNT, Q2 2026
Go to the superinvestors tabNo superinvestor reported holding XTNT at the end of Q2 2026.
Latest insider trades
See all insider tradesOpen-market purchases and sales by Xtant Medical Holdings, Inc. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Apr 14, 2025 (view filing)7:14 PM ET | Apr 10 | 4 days | OrbiMed Advisors LLC and 1 other10% Owner | SSale | −73.1M | $0.42 | −$30.7M | −100.0%0 after | 2 lots |
| Nov 17, 2023 (view filing) | Nov 17 | Same day | Brandt Kevin DChief Commercial Officer | PPurchase | +41.7K | $1.20 | +$50.0K | +5.4%815.9K after | |
| Jan 19, 2023 (view filing) | Jan 18 | 1 day | Neils Scott CChief Financial Officer | SSaleCommon Stock, $0.000001 par value | −8.67K | $0.61 | −$5.29K | −2.1%404.0K after | |
| Oct 20, 2022 (view filing) | Oct 18-19 | 2 days | Browne Sean EPresident and CEO | SSaleCommon Stock, $0.000001 par value | −131.1K | $0.6566 | −$86.1K | −8.0%1.51M after | 2 lots |
| Oct 11, 2022 (view filing)4:48 PM ET | Oct 7 | 4 days | Vizirgianakis Stavros G.Director | PPurchaseCommon Stock, $0.000001 par value | +2.26M | $0.48 | +$1.09M | +63.2%5.85M after | |
| Oct 11, 2022 (view filing)4:48 PM ET | Oct 7 | 4 days | Vizirgianakis Stavros G.Director | PPurchase | +566.2K | $0.00 | $0 | –566.2K after | Derivative |
| Aug 17, 2022 (view filing)5:28 PM ET | Aug 16-17 | 1 day | Brandt Kevin DChief Commercial Officer | SSaleCommon Stock, $0.000001 par value | −23.0K | $0.4879 | −$11.2K | −3.2%703.6K after | 2 lots |
| Aug 17, 2022 (view filing)5:10 PM ET | Aug 16-17 | 1 day | Neils Scott CChief Financial Officer | SSaleCommon Stock, $0.000001 par value | −6.37K | $0.4812 | −$3.07K | −1.5%412.6K after | 2 lots |
Top 10 13F holders, Q2 2026
See all 33 holdersThe largest institutional positions in Xtant Medical Holdings, Inc. at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Nantahala Capital Management, LLC | 68,394,000 | $28.8M | 1.74% | 00.0% | Unchanged |
| AWM Investment Company, Inc. | 5,976,910 | $2.52M | 0.22% | 00.0% | Unchanged |
| Vanguard Capital Management LLC | 2,014,603 | $848.1K | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 935,119 | $393.7K | 0.00% | −52,291−5.3% | Reduced |
| Geode Capital Management, LLC | 517,133 | $217.8K | 0.00% | −12,081−2.3% | Reduced |
| Crescent Grove Advisors, LLC | 412,024 | $173.5K | 0.01% | 00.0% | Unchanged |
| Nano Cap New Millennium Growth Fund L P | 400,000 | $168.4K | 0.13% | +50,000+14.3% | Added |
| Vanguard Fiduciary Trust Co | 257,988 | $108.6K | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 191,369 | $80.6K | 0.00% | +30,358+18.9% | Added |
| Acadian Asset Management LLC | 180,299 | $73.0K | 0.00% | 00.0% | Unchanged |
Holders of 5% or more of XTNT
See all 2 holders and filingsHolders whose latest Schedule 13D or 13G filing reports 5% or more of Xtant Medical Holdings, Inc..
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Nantahala Capital Management, LLC | 13D/A | 49.10%68.4M shares | 0.00 ppfrom 49.10% | Nov 14, 20243 filings | Aug 5, 2025 | SEC |
| Lytton Laurence W | 13G/A | 5.50%7.70M shares | −1.30 ppfrom 6.80% | Apr 16, 20252 filings | Feb 17, 2026 | SEC |